Over 12 months, Adma Biologics, Inc. saw more selling than buying from its insiders — purchases of about $468,000 against sales of $1.9 million.
ELMS STEVE (Director) made the biggest buy, worth around $110,000.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 2 of the last 7 full quarters. On the institutional side, 323 funds reported holding ADMA at the end of Q2 2026, and more funds sold than bought.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| May 28, 2026 | Grossman Jerrold B | Director | Buy | 6,400 | $7.91 | $51K | SEC |
| May 14, 2026 | Grossman Jerrold B | Director | Buy | 12,500 | $8.01 | $100K | SEC |
| May 12, 2026 | Grossman Jerrold B | Director | Buy | 12,500 | $8.01 | $100K | SEC |
| Mar 17, 2026 | Grossman Adam S | CEO | Sell | 6,000 | $15.16 | $91K | SEC |
| Mar 17, 2026 | Grossman Adam S | CEO | Sell | 15,000 | $15.16 | $227K | SEC |
| Mar 10, 2026 | Kestenberg-Messina Kaitlin M. | COO | Sell | 10,096 | $15.63 | $158K | SEC |
| Mar 9, 2026 | ELMS STEVE | Director | Buy | 7,000 | $15.67 | $110K | SEC |
| Mar 9, 2026 | ELMS STEVE | Director | Buy | 7,000 | $15.39 | $108K | SEC |
| Feb 17, 2026 | Grossman Adam S | CEO | Sell | 6,000 | $16.08 | $96K | SEC |
| Feb 17, 2026 | Grossman Adam S | CEO | Sell | 15,000 | $16.08 | $241K | SEC |
| Dec 16, 2025 | Grossman Adam S | CEO | Sell | 6,000 | $19.79 | $119K | SEC |
| Dec 16, 2025 | Grossman Adam S | CEO | Sell | 15,000 | $19.79 | $297K | SEC |
| Nov 21, 2025 | Grossman Adam S | CEO | Sell | 6,000 | $16.00 | $96K | SEC |
| Nov 21, 2025 | Grossman Adam S | CEO | Sell | 15,000 | $16.00 | $240K | SEC |
| Oct 24, 2025 | Grossman Adam S | CEO | Sell | 6,000 | $16.00 | $96K | SEC |
In the last 12 months Adma Biologics, Inc. insiders made open-market purchases worth about $468,000 and sales worth about $1.9 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in ADMA was filed on 2026-05-28.
323 investment managers reported holding ADMA in SEC Form 13F filings for Q2 2026.
No congressional trades in ADMA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).